Grand Rapids leaders to discuss city's future at policy conference
Discussions will focus on key issues shaping the city, including housing. Grand Rapids Mayor David LaGrand is set to outline his vision for the city, while Michigan House Speaker Matt Hall, R-Richland, will address state policies affecting West Michigan. Sam Cummings of property management firm CWD will present a plan to convert office space into housing, and guest speaker Marc Eichenbaum from Houston will share insights on ending chronic homelessness. He spent 11 years there as the mayor's special assistant for homeless initiatives.
The event begins at 7:30 a.m. with networking and breakfast, followed by opening remarks at 8 a.m. Admission costs $200 for chamber members and $250 for non-members. While preregistration has closed, walk-in registration is available.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
AstraZeneca pledges $50bn investment in the US amid 200% tariff fears
AstraZeneca will invest $50 billion (€42.8 bn) in the US by 2030 in a move to expand its R&D and manufacturing there, the firm announced on Monday. This comes as the pharmaceutical giant aims to reach the target of $80 billion (€68.5 bn) in revenue by 2030, with 50% of it hoped to come from the US. The announcement also comes as the Trump administration threatens tariffs of up to 200% on drugs that are produced outside of the US. The new investment announcement is in addition to the $3.5 billion (€3 bn) pledged in November 2024. According to a statement from the company, the US plays a 'critical role' in AstraZeneca's ability 'to launch 20 new medicines by the end of the decade'. What will AstraZeneca produce in the US? As part of the investment, the British-Swedish company plans to build a new multi-billion dollar manufacturing facility in the state of Virginia. This plant will focus on the production of treatments for chronic diseases and is the largest single investment into a facility the company has ever made. '[This] announcement underpins our belief in America's innovation in biopharmaceuticals and our commitment to the millions of patients who need our medicines in America and globally,' Pascal Soriot, Chief Executive Officer at AstraZeneca said in a statement from the company. 'I look forward to partnering with Governor Youngkin and his team to work on our largest single manufacturing investment ever. It reflects the Commonwealth of Virginia's desire to create highly skilled jobs in science and technology, and will strengthen the country's domestic supply chain for medicines.' Related Revolut to create 400 new jobs as Paris HQ leads hopes towards French banking licence Universal Music Group confidentially files for US stock market listing The site in Virginia will have a particular focus on producing substances which make up AstraZeneca's weight management and metabolic treatment portfolio. As well as the site in Virginia, the investment will help expand facilities and production in Massachusetts, Maryland, California, Indiana and Texas, as well as finding new sites for clinical trials. AstraZeneca already has 19 R&D, manufacturing and commercial sites in the US, and the country is the company's largest market, representing 42% of their revenue. The firm currently employs more than 18,000 people and supports 92,000 jobs across the US. The new investment announcement is expected to create tens of thousands more jobs in the coming years. Howard Lutnick, US Secretary of Commerce, said: 'For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness. We are proud that AstraZeneca has made the decision to bring substantial pharmaceutical production to our shores. This historic investment is bringing tens of thousands of jobs to the US and will ensure medicine sold in our country is produced right here.' Sign in to access your portfolio
Politico
19 hours ago
- Politico
GOP megabill's final score: $3.4T in red ink and 10 million kicked off health insurance, CBO says
The package President Donald Trump signed on July 4 would grow the deficit over the next 10 years, Congress' nonpartisan scorekeeper predicts. House Speaker Mike Johnson (R-La.) and House Majority Leader Steve Scalise (R-La.) react as they arrive for a signing ceremony for a budget reconciliation bill for President Trump's legislative agenda at the U.S. Capitol July 3, 2025. (Francis Chung/POLITICO via AP Images) | AP By Jennifer Scholtes Robert King and Benjamin Guggenheim 07/21/2025 02:32 PM EDT Congress' nonpartisan scorekeeper released its final prediction Monday for how President Donald Trump's signature legislative achievement will grow the national debt and affect U.S. households. Over the next decade, the megabill Trump signed on July 4 would increase the federal deficit by $3.4 trillion and cause 10 million people to lose health insurance, the Congressional Budget Office forecasts. While the newly enacted legislation would save more than $1 trillion by cutting federal spending on health care — with the majority coming from Medicaid — CBO predicts that the package's costs will far outweigh its savings. The bulk of the red ink from the package comes from the GOP's permanent extension of Trump's 2017 tax cuts. The analysis finds that the Senate Finance Committee, which has jurisdiction over tax policy, enacted policies that would decrease the incoming federal cash flow from taxes by a total of $4.5 trillion. That sum includes the cost of tax cuts Republicans added during Senate floor debate of the package.
Yahoo
19 hours ago
- Yahoo
Job hunting? These are the 3 best MS companies to work for, says US News & World Report
Job hunting in Mississippi? Great news! The Magnolia State has some of the best employers in the country. Recently, U.S. News & World Report released its list of the best companies to work for, which included three headquartered in Mississippi. This was determined by looking at 5,000 large publicly traded companies, analyzing metrics like pay and comfort, and giving each a score. Categories were given a 1-5 ranking, with 5 being the best. KLLM KLLM is a Richland-based transportation company that's one of the biggest temperature-controlled trucking carriers in the country. It was founded in 1963 and now has an annual revenue between $500 million and $1 billion and it employees between 5,000 and 10,000 people. Quality of pay: 5 Work-life balance: 3 Stability: 4 Comfort: 5 Belongingness: 4 Professional development: 3 The First The First is based in Hattiesburg. Founded in 1996, this finance and insurance firm achieved perfect scores in work-life balance, comfort, and belonging. U.S. News ranked it as one of the best companies to work in the South. In April, the bank merged with Renasant Corporation in Tupelo. According to a news release, The First's operations are expected to be fully integrated with Renasant by August. Quality of pay: 3 Work-life balance: 5 Stability: 4 Comfort: 5 Belongingness: 5 Professional development: 3 More: South Mississippi home to state's three top employers. Can you guess which ones? Yates Construction Yates Construction is based in Philadelphia, MS. The engineering and construction firm was founded in 1963. Today, it has an annual revenue between $1 billion and $10 billion. Quality of pay: 5 Work-life balance: 4 Stability: 3 Comfort: 4 Belongingness: 3 Professional development: 1 Miguel Legoas is a Deep South Connect Team Reporter for Gannett/USA Today. Find him on Instagram @miguelegoas and email at mlegoas@ Bonnie Bolden is the Deep South Connect reporter for Mississippi with Gannett/USA Today. Email her at bbolden@ This article originally appeared on Mississippi Clarion Ledger: US News & World Report names best companies to work for in MS 2025 Solve the daily Crossword
